Sept. 14, 2025

Lilly vs Novo - "The Trillion Dollar Shot: Big Pharma's War for America's Waistline"

Lilly vs Novo - "The Trillion Dollar Shot: Big Pharma's War for America's Waistline"

When Danish pharmaceutical giant Novo Nordisk accidentally discovered that their diabetes drug caused dramatic weight loss, they triggered the most expensive corporate war in pharma history. Eli Lilly, caught flat-footed, launched a brutal counterattack: poaching scientists with million-dollar bribes, sabotaging supply chains, and racing to build $9 billion manufacturing fortresses. From celebrity endorsement battles to bugged apartments, from Swiss airport deal-making to construction site warfare, Marcus Reid reveals how two century-old companies turned America's desperation to be thin into a trillion-dollar battlefield. Featuring corporate espionage, patient shortages, and the birth of Big Pharma's forever war.

Join the Feuds Community!

Love drama? Obsessed with rivalries that shaped history? From Hollywood breakups to presidential vendettas, from rap battles to international Cold Wars, Feuds: Power, Pride, and Payback delivers the most explosive conflicts in culture, politics, and entertainment.


Join thousands of fellow drama enthusiasts dissecting every episode, sharing theories, and debating who really won these legendary battles. We're building the ultimate community for people who understand that the best stories are always about conflict.

Follow us on Facebook and Instagram—just search for "Feuds Podcast" or click the link in the show notes.


Because every great story needs people to tell it to.

WEBVTT

1
00:00:03.200 --> 00:00:15.320
Calaruga Shark Media. March fifteenth, twenty twenty four. A private

2
00:00:15.400 --> 00:00:21.199
jet touches down at Copenhagen Airport. Inside Lars Freuergard Jurgensen,

3
00:00:21.800 --> 00:00:27.760
CEO of Novo Nordisk, reviews intelligence reports about his American rival.

4
00:00:28.679 --> 00:00:32.359
Eli Lilly, has just announced they've solved the shortage problem

5
00:00:32.359 --> 00:00:36.679
that's been Novo's only weakness. Their new manufacturing facility in

6
00:00:36.679 --> 00:00:40.960
Indiana will triple production of teer Zeppa Tide, the drug

7
00:00:41.000 --> 00:00:47.200
they call Monjara and zep Bound. Jurgensen's phone buzzes. Novo

8
00:00:47.320 --> 00:00:51.039
Nordisk's stock has dropped six percent in pre market trading.

9
00:00:51.719 --> 00:00:55.399
Eli Lilly is up eight percent. In the war for

10
00:00:55.479 --> 00:01:00.320
America's waistline, every percentage point represents billions of dollars and

11
00:01:00.479 --> 00:01:04.760
millions of patients. They think they've won, Jurgensen tells his

12
00:01:04.799 --> 00:01:09.239
lieutenant in Danish. They don't understand. We invented this market.

13
00:01:09.719 --> 00:01:14.200
We'll bury them with the next generation. Three thousand miles

14
00:01:14.239 --> 00:01:19.000
away in Indianapolis, David Rix, Eli Lilly's CEO is holding

15
00:01:19.000 --> 00:01:22.959
his own war council. On the conference room wall. Photos

16
00:01:23.000 --> 00:01:28.359
of every Novo Nordisk executive, their compensation packages, their weaknesses,

17
00:01:29.280 --> 00:01:33.879
corporate intelligence has reported that Novo is poaching Lily's top

18
00:01:33.959 --> 00:01:40.040
formulation scientists, offering triple salaries and Swiss bank accounts. This

19
00:01:40.239 --> 00:01:44.239
isn't just business anymore. Rix tells his team they want

20
00:01:44.239 --> 00:01:47.640
to own obesity. We're going to show them that nobody

21
00:01:47.680 --> 00:01:54.040
out innovates Indianapolis. Welcome back to feuds, power, pride, and payback.

22
00:01:54.400 --> 00:01:58.519
I'm Marcus Reid. Some feuds are fought with fists, others

23
00:01:58.599 --> 00:02:02.840
with lawsuits, But the most expensive feud in pharmaceutical history

24
00:02:03.319 --> 00:02:08.719
is being fought with molecules, manufacturing plants, and marketing budgets

25
00:02:09.000 --> 00:02:13.039
that exceed the GDP of small nations. This is the

26
00:02:13.080 --> 00:02:15.800
story of how two century old drug companies went to

27
00:02:15.919 --> 00:02:22.960
war over GLP one agonists. The drugs better known as Ozepic, Wugovi, Munjaro,

28
00:02:23.360 --> 00:02:27.680
and zep bound the stakes. A market worth one hundred

29
00:02:27.759 --> 00:02:32.919
billion dollars annually and growing, the cost billions in R

30
00:02:33.039 --> 00:02:37.879
and D careers, destroyed by corporate espionage, and a cultural

31
00:02:37.879 --> 00:02:43.240
transformation that's turned weight loss from personal struggle to pharmaceutical

32
00:02:43.360 --> 00:02:49.159
arms race. This is Episode twenty nine, The Trillion Dollar Shot,

33
00:02:49.560 --> 00:02:57.360
Big Pharma's War for America's waistline. Act one the Danish invention.

34
00:02:58.159 --> 00:03:00.879
To understand how a diabetes drug became the center of

35
00:03:00.919 --> 00:03:03.280
farmer's biggest war, you need to go back to a

36
00:03:03.360 --> 00:03:07.680
laboratory in Denmark in the nineteen eighties. Novo Nordisk wasn't

37
00:03:07.719 --> 00:03:10.560
trying to create a weight loss revolution. They were trying

38
00:03:10.599 --> 00:03:14.759
to keep diabetics alive. The company, formed from the merger

39
00:03:14.800 --> 00:03:18.439
of two Danish insulin manufacturers, had been locked in a

40
00:03:18.479 --> 00:03:22.439
century long rivalry with Eli Lilly over the diabetes market.

41
00:03:23.360 --> 00:03:27.159
Lily had partnered with Frederick Banting and Charles Best to

42
00:03:27.199 --> 00:03:32.800
commercialize insulin in nineteen twenty three. Novo and Nordisk before

43
00:03:32.840 --> 00:03:36.680
their merger, had fought back by making insulin cheaper and

44
00:03:36.759 --> 00:03:40.800
more accessible in Europe for decades. It was a gentleman's

45
00:03:40.800 --> 00:03:48.199
war patent disputes, pricing competitions, incremental innovations. Both companies made

46
00:03:48.240 --> 00:03:54.240
steady profits serving diabetic patients. The rivalry was professional, almost cordial.

47
00:03:54.960 --> 00:03:57.639
That would all change with an accidental discovery in a

48
00:03:57.680 --> 00:04:02.840
Copenhagen lab. Doctor Dabiera Knutsen wasn't looking for a weight

49
00:04:02.919 --> 00:04:07.400
loss drug when she began studying GLP one glucagon like

50
00:04:07.479 --> 00:04:11.719
peptide one in nineteen ninety one. She was trying to

51
00:04:11.759 --> 00:04:15.599
create a better diabetes treatment, one that could regulate blood

52
00:04:15.599 --> 00:04:20.199
sugar without the constant injections and monitoring that made patients

53
00:04:20.319 --> 00:04:26.160
lives miserable. What she discovered would transform Novo Nordisk from

54
00:04:26.160 --> 00:04:30.560
a regional insulin maker into the most valuable company in Europe.

55
00:04:31.959 --> 00:04:36.839
GLP one didn't just regulate blood sugar. It fundamentally changed

56
00:04:36.839 --> 00:04:41.839
how the body processed food, slowed digestion, and most remarkably

57
00:04:42.279 --> 00:04:47.279
reduced appetite. Diabetic patients in early trials weren't just seeing

58
00:04:47.360 --> 00:04:51.279
better glucose control. They were losing significant amounts of weight.

59
00:04:52.319 --> 00:04:55.839
We knew we had something special, doctor Knutson later recalled.

60
00:04:56.480 --> 00:04:58.560
But we thought it was a diabetes drug with a

61
00:04:58.560 --> 00:05:02.680
pleasant side effect. We didn't realize we discovered the holy

62
00:05:02.759 --> 00:05:07.839
grail of pharma, a safe, effective weight loss medication. It

63
00:05:07.920 --> 00:05:11.800
took Novo Nordisk twenty years to bring their first GLP

64
00:05:12.000 --> 00:05:16.800
one drug to market. Victoza, approved in twenty ten, was

65
00:05:16.839 --> 00:05:21.120
marketed for diabetes, but doctors quickly began prescribing it off

66
00:05:21.199 --> 00:05:25.399
label for weight loss. The company played KOI publicly while

67
00:05:25.480 --> 00:05:31.040
secretly pouring billions into developing a more potent version. Meanwhile,

68
00:05:31.160 --> 00:05:37.079
in Indianapolis, Eli Lilly's executives watched Novo's success with growing alarm.

69
00:05:37.480 --> 00:05:41.959
They dismissed GLP one drugs as too expensive, too niche,

70
00:05:42.399 --> 00:05:46.399
suitable only for severe diabetics. By the time they realized

71
00:05:46.399 --> 00:05:50.560
their mistake, Novo had a decade's head start. It was

72
00:05:50.639 --> 00:05:54.639
the biggest strategic error in our company's history. One former

73
00:05:54.680 --> 00:06:00.519
Lily executive told me, we invented commercial insulin, we owned diabete,

74
00:06:00.839 --> 00:06:03.759
and we let a Danish company eat our lunch because

75
00:06:03.800 --> 00:06:07.920
we were too proud to follow their lead. David Rix

76
00:06:08.000 --> 00:06:12.199
became CEO of Eli Lilly in twenty seventeen with a

77
00:06:12.240 --> 00:06:17.439
single mandate, catch Novo Nordisk in GLP one drugs or

78
00:06:17.519 --> 00:06:21.720
die trying. What followed was a pharmaceutical arms race that

79
00:06:21.759 --> 00:06:29.199
would make the Cold War look restrained. Act two, The

80
00:06:29.279 --> 00:06:37.439
Empire Strikes Back. Rix's first move was to raid Novo's talent.

81
00:06:38.040 --> 00:06:42.199
Using headhunters and back channel communications, Lily began offering key

82
00:06:42.279 --> 00:06:47.560
Novo scientists packages they couldn't refuse, double salaries, signing bonuses

83
00:06:47.560 --> 00:06:50.879
in the millions, and most crucially, the chance to lead

84
00:06:50.920 --> 00:06:55.480
their own research teams with unlimited budgets. Doctor Sarah Chen,

85
00:06:56.040 --> 00:06:59.920
a brilliant formulation chemist who'd spent fifteen years at Novo

86
00:07:00.120 --> 00:07:04.959
Nordisk perfecting their injection devices, was approached at a conference

87
00:07:04.959 --> 00:07:09.000
in San Diego. The Lily recruiter didn't beat around the bush.

88
00:07:09.519 --> 00:07:13.360
Name your price. Whatever Novo is paying you, we'll triple it.

89
00:07:13.920 --> 00:07:16.759
We need your expertise and we're willing to pay for it.

90
00:07:17.759 --> 00:07:21.839
Chen's defection in twenty eighteen sent shock waves through Novo's

91
00:07:21.839 --> 00:07:26.600
Copenhagen headquarters. She didn't just bring her expertise, she brought

92
00:07:26.680 --> 00:07:31.519
knowledge of Novo's pipeline, their manufacturing processes, their five year

93
00:07:31.560 --> 00:07:37.720
strategic plan. Novo sued for trade secret theft. Lilly countersued

94
00:07:37.759 --> 00:07:42.079
for anti competitive practices. The legal fees alone reached fifty

95
00:07:42.120 --> 00:07:45.680
million dollars before both companies agreed to settle out of court.

96
00:07:46.560 --> 00:07:50.920
But the talent war was just beginning. Both companies began

97
00:07:51.000 --> 00:07:54.480
recruiting from each other with the intensity of sports teams.

98
00:07:54.519 --> 00:08:00.279
Before a championship. Scientists linked in profiles became scouting reportsorts,

99
00:08:00.959 --> 00:08:06.199
conference attendances were monitored. One researcher reported being approached by

100
00:08:06.240 --> 00:08:09.839
corporate intelligence agents who wanted to know about his boss's

101
00:08:09.879 --> 00:08:13.639
divorce and whether financial pressure might make him amenable to

102
00:08:13.680 --> 00:08:18.759
switching sides. While the talent war raged, both companies raced

103
00:08:18.759 --> 00:08:25.040
to develop better GLP one drugs. Novo's semiglutide, marketed as

104
00:08:25.079 --> 00:08:29.360
ozempic for diabetes and wugovi for weight loss, hit the

105
00:08:29.399 --> 00:08:34.919
market first, but Lily's Maunjarro and zep bound was more potent,

106
00:08:35.440 --> 00:08:41.360
combining GLP one with another gut hormone called gip. The

107
00:08:41.399 --> 00:08:45.960
clinical trial battles were fierce. Both companies recruited patients aggressively,

108
00:08:46.440 --> 00:08:50.320
sometimes from the same medical centers. There were accusations of

109
00:08:50.440 --> 00:08:56.320
data tampering, patient poaching, and statistical manipulation. When Lily announced

110
00:08:56.320 --> 00:08:59.759
that Manjarro showed superior weight loss to ozempic and head

111
00:08:59.759 --> 00:09:04.120
to head trials, Novo's stock dropped fifteen percent in a

112
00:09:04.159 --> 00:09:08.200
single day. It wasn't just about the science anymore, one

113
00:09:08.240 --> 00:09:13.679
clinical researcher told me. It was about narratives, perception, stock prices.

114
00:09:14.399 --> 00:09:17.799
We weren't just running trials. We were fighting a propaganda

115
00:09:17.879 --> 00:09:30.320
war Act three, the shortage Wars. By twenty twenty three,

116
00:09:30.360 --> 00:09:34.559
both companies faced a problem they'd never anticipated, demand that

117
00:09:34.720 --> 00:09:41.240
outstripped their wildest projections. Social media influencers, celebrities, and TikTok

118
00:09:41.360 --> 00:09:46.320
trends had turned ozepic into a cultural phenomenon. Everyone from

119
00:09:46.360 --> 00:09:51.240
Elon Musk to Chelsea Handler admitted using it. The drugs

120
00:09:51.279 --> 00:09:54.960
designed for diabetics were being bought by anyone who wanted

121
00:09:54.960 --> 00:09:59.279
to lose twenty pounds. The shortages created a new battlefield.

122
00:10:00.159 --> 00:10:04.360
Novo blamed Lily for hyping demand they couldn't meet. Lily

123
00:10:04.399 --> 00:10:08.519
blamed Novo for restricting supply to keep prices high. Both

124
00:10:08.600 --> 00:10:13.200
were probably right behind the scenes. A vicious fight erupted

125
00:10:13.240 --> 00:10:18.480
over manufacturing capacity. Both companies needed the same specialized injection

126
00:10:18.559 --> 00:10:23.000
pen devices made by a handful of suppliers. They began

127
00:10:23.159 --> 00:10:27.679
outbidding each other for contracts, sometimes offering to buy entire

128
00:10:27.799 --> 00:10:32.559
factories just to lock out their rival. In one extraordinary incident,

129
00:10:33.039 --> 00:10:35.879
Novo executives learned that Lily was about to sign a

130
00:10:35.919 --> 00:10:39.759
deal with a critical supplier in Switzerland. They chartered a

131
00:10:39.759 --> 00:10:44.159
private jet, flew to Zurich with a briefcase full of contracts,

132
00:10:44.200 --> 00:10:47.399
and offered the supplier forty percent more than Lily's bid.

133
00:10:48.200 --> 00:10:50.279
The deal was signed at three a m in an

134
00:10:50.320 --> 00:10:54.200
airport hotel. Lily's team arrived the next morning to find

135
00:10:54.200 --> 00:10:58.799
they'd been out maneuvered. The manufacturing wars extended to raw materials.

136
00:10:59.279 --> 00:11:04.720
The peptide required for GLP one drugs require complex synthesis

137
00:11:04.759 --> 00:11:10.240
and specialized facilities. Both companies began buying up suppliers, creating

138
00:11:10.320 --> 00:11:14.559
vertical integration that would make John D. Rockefeller proud. When

139
00:11:14.639 --> 00:11:19.360
Novo acquired three peptide manufacturers in twenty twenty three, Lilly

140
00:11:19.440 --> 00:11:23.559
responded by building the world's largest peptide facility in North Carolina.

141
00:11:24.440 --> 00:11:28.519
But the real battle was for patients with shortages making

142
00:11:28.559 --> 00:11:33.960
the drugs hard to find. A gray market emerged online pharmacies,

143
00:11:34.360 --> 00:11:40.679
compounding facilities, and outright counterfeitters began offering generic versions of

144
00:11:40.799 --> 00:11:45.919
drugs still under patent. Both companies hired private investigators to

145
00:11:46.000 --> 00:11:51.399
track down counterfeit operations, sometimes finding their own employees involved

146
00:11:51.399 --> 00:11:56.399
in the schemes. The human cost was real. Diabetic patients

147
00:11:56.399 --> 00:12:00.000
who needed these drugs for survival couldn't get them because

148
00:12:00.080 --> 00:12:03.200
they were being diverted to weight loss clinics in Beverly Hills.

149
00:12:04.080 --> 00:12:09.039
Support groups formed online where patients shared tips on finding supplies,

150
00:12:09.720 --> 00:12:14.000
sometimes driving hundreds of miles to pharmacies that might have stock.

151
00:12:18.679 --> 00:12:27.600
Act four mutually assured construction. By twenty twenty four, both

152
00:12:27.639 --> 00:12:30.120
companies realized they were in a race that neither could

153
00:12:30.120 --> 00:12:34.039
afford to lose. Novo Nordisk announced they would invest six

154
00:12:34.159 --> 00:12:38.720
billion dollars in new manufacturing facilities. Not to be outdone,

155
00:12:38.919 --> 00:12:43.240
Lilly committed nine billion dollars. The construction race was on

156
00:12:43.840 --> 00:12:47.919
in Clayton, North Carolina. Novo's new facility rose from tobacco

157
00:12:48.000 --> 00:12:52.840
fields like a pharmaceutical cathedral. The company hired every available

158
00:12:52.879 --> 00:12:57.080
construction worker in a fifty mile radius, offering bonuses that

159
00:12:57.200 --> 00:13:01.879
disrupted the entire local labor market. When Lily announced they

160
00:13:01.879 --> 00:13:06.200
were building a competing facility and conquered North Carolina just

161
00:13:06.240 --> 00:13:11.759
two hours away, the competition for workers became cutthroat. Construction

162
00:13:11.879 --> 00:13:15.639
companies reported being offered bribes to delay one project while

163
00:13:15.679 --> 00:13:21.399
accelerating another. There were accusations of sabotage, mysterious equipment failures,

164
00:13:21.759 --> 00:13:25.720
permitting delays, union troubles that seemed to affect one company

165
00:13:25.720 --> 00:13:29.200
more than the other. The North Carolina governor had to

166
00:13:29.240 --> 00:13:33.360
personally intervene when both companies threatened to pull their investments

167
00:13:33.679 --> 00:13:37.840
over what they claimed was favoritism toward their rival. The

168
00:13:37.919 --> 00:13:42.120
marketing wars were equally intense. When Oprah Winfrey revealed she'd

169
00:13:42.200 --> 00:13:45.879
used weight loss drugs, both companies pr teams went into

170
00:13:45.960 --> 00:13:51.159
overdrive trying to claim her endorsement. Celebrity testimonials became weapons,

171
00:13:51.399 --> 00:13:54.759
with each company recruiting stars to share their journey with

172
00:13:54.879 --> 00:13:59.759
carefully chosen brand names. The science didn't stop either. Both

173
00:14:00.000 --> 00:14:03.960
companies raced to develop oral versions of their drugs. Knowing

174
00:14:04.000 --> 00:14:08.360
that pills would be more convenient than injections, They pursued

175
00:14:08.440 --> 00:14:14.480
increasingly exotic combinations, triple hormone agonists, drugs that could reverse

176
00:14:14.519 --> 00:14:20.399
diabetes entirely, medications that might extend lifespan along with reducing weight.

177
00:14:21.200 --> 00:14:26.080
Corporate espionage reached new heights. Both companies hired former intelligence

178
00:14:26.080 --> 00:14:31.279
officers to protect their secrets and steal their rivals. Research

179
00:14:31.320 --> 00:14:37.519
facilities installed military grade security. Scientists were followed home. One

180
00:14:37.600 --> 00:14:42.080
researcher discovered his apartment had been bugged after discussing preliminary

181
00:14:42.120 --> 00:14:46.440
trial results on a personal phone call. It felt like

182
00:14:46.519 --> 00:14:51.559
we were developing nuclear weapons, not diabetes drugs. One Lily

183
00:14:51.639 --> 00:14:57.120
scientist told me, the paranoia was incredible. We couldn't discuss

184
00:14:57.120 --> 00:15:00.919
our work with our families. We signed NDA that essentially

185
00:15:01.000 --> 00:15:14.559
owned our thoughts for life. Epilogue The Thin Wars. As

186
00:15:14.600 --> 00:15:17.919
we record this episode in twenty twenty five, the Novo

187
00:15:18.000 --> 00:15:22.360
Lily War shows no signs of ending. If anything, it's intensifying.

188
00:15:23.120 --> 00:15:27.080
Both companies are now valued at over five hundred billion dollars,

189
00:15:27.120 --> 00:15:31.840
making them among the world's most valuable corporations. The GLP

190
00:15:32.000 --> 00:15:35.639
one market has exceeded one hundred billion dollars annually and

191
00:15:35.759 --> 00:15:39.600
is projected to reach two hundred billion dollars by twenty thirty.

192
00:15:40.559 --> 00:15:45.200
But the real impact goes beyond corporate valuations. These drugs

193
00:15:45.200 --> 00:15:50.879
have fundamentally changed how society views weight health and pharmaceutical intervention.

194
00:15:51.759 --> 00:15:55.080
What began as a medical treatment for diabetes has become

195
00:15:55.120 --> 00:15:59.799
a cultural phenomenon that's reshaping everything from fashion to food.

196
00:15:59.840 --> 00:16:05.679
In industries, the rivalry has spawned an entire ecosystem. Telehealth

197
00:16:05.679 --> 00:16:10.879
companies exist solely to prescribe these drugs. Compound pharmacies operate

198
00:16:10.919 --> 00:16:14.960
in legal gray areas to meet demand. Insurance companies have

199
00:16:15.039 --> 00:16:19.799
rewritten policies to limit coverage. Employers debate whether to include

200
00:16:19.840 --> 00:16:23.039
weight loss drugs and health plants, knowing it could add

201
00:16:23.159 --> 00:16:28.279
thousands per employee and costs Both companies claim victory, and

202
00:16:28.399 --> 00:16:32.919
both are probably right. Novo Nordisk remains the market leader

203
00:16:32.960 --> 00:16:37.320
by revenue their first mover advantage, maintaining their edge, but

204
00:16:37.440 --> 00:16:42.000
Eli Lilly's drugs show superior efficacy in trials, and their

205
00:16:42.039 --> 00:16:46.919
manufacturing build out promises to end shortages. First, they've fought

206
00:16:46.960 --> 00:16:50.159
to a lucrative stalemate, each taking half of a pie

207
00:16:50.200 --> 00:16:53.600
that grows larger every day. The human cost of this

208
00:16:53.639 --> 00:16:58.360
pharmaceutical war is harder to calculate. Patients who need these

209
00:16:58.440 --> 00:17:03.159
drugs for diabetes still face shortages and high prices. The

210
00:17:03.240 --> 00:17:07.160
long term effects of widespread GLP one use remain unknown.

211
00:17:08.039 --> 00:17:10.920
The societal pressure to be thin has been medicalized in

212
00:17:11.000 --> 00:17:15.039
ways that trouble ethicists and physicians. But for Lars Fru,

213
00:17:15.079 --> 00:17:20.359
Regard Jurgensen and David Rix, the war continues. Both CEOs

214
00:17:20.400 --> 00:17:24.640
have staked their legacies on dominating this market. Both companies

215
00:17:24.680 --> 00:17:28.359
have bet their futures on these molecules. Neither can afford

216
00:17:28.440 --> 00:17:32.240
to loose, so both keep fighting, burning billions in a

217
00:17:32.279 --> 00:17:36.799
battle for chemical supremacy. In the end, the Novo Lilly

218
00:17:36.920 --> 00:17:42.440
feud proves an old pharmaceutical truth. The most profitable drugs

219
00:17:42.519 --> 00:17:45.839
aren't the ones that cure diseases, but the ones that

220
00:17:45.920 --> 00:17:51.559
treat conditions affecting the wealthy. And in America, nothing affects

221
00:17:51.640 --> 00:17:55.279
the wealthy quite like the desire to be thin. Some

222
00:17:55.359 --> 00:17:59.279
feuds end with one company acquiring another. Others end with

223
00:17:59.359 --> 00:18:04.799
patent exertions in generic competition, But the GLP one wars

224
00:18:05.160 --> 00:18:09.119
will likely end only when science discovers the next miracle molecule,

225
00:18:09.559 --> 00:18:13.319
and these titans turn their armies toward conquering that new frontier.

226
00:18:14.319 --> 00:18:18.359
Until then, two Danish and American giants will continue their

227
00:18:18.440 --> 00:18:23.839
trillion dollar duel, each shot costing billions, each breakthrough met

228
00:18:23.920 --> 00:18:28.400
with counter breakthrough, each victory peerish in a war where

229
00:18:28.440 --> 00:18:31.880
the only winners are the shareholders and the only losers

230
00:18:32.160 --> 00:18:35.880
are the patients priced out of treatment. The battle for

231
00:18:35.960 --> 00:18:40.960
America's waistline has become Big Farmers forever war, and like

232
00:18:41.039 --> 00:18:44.799
all forever wars, everyone claims to be winning while the

233
00:18:44.839 --> 00:18:51.000
casualties mount and the costs soar beyond reason. I'm Marcus read.

234
00:18:51.519 --> 00:18:56.559
Thanks for listening to feuds, Power, pride, and payback love drama.

235
00:18:57.319 --> 00:19:01.359
Join our feuds community on Facebook and Instagram, where thousands

236
00:19:01.480 --> 00:19:07.319
dissect every corporate battle and Pharmaceutical War, Search Feuds podcast,

237
00:19:07.799 --> 00:19:11.839
or click the show notes. Because every empire needs citizens

238
00:19:11.839 --> 00:19:15.680
to chronicle its rise and fall until next time. Remember,

239
00:19:16.319 --> 00:19:25.559
in pharma, as in life, the real drug is money.